Neurocrine Biosciences, Inc. (NBIX)
158.42
-0.63
(-0.40%)
USD |
NASDAQ |
May 15, 16:00
158.37
-0.05
(-0.03%)
After-Hours: 07:12
Neurocrine Biosciences Market Cap : 15.93B for May 15, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Soleno Therapeutics, Inc. | 2.763B |
| Biogen, Inc. | 28.49B |
| Nuvalent, Inc. | 8.081B |
| Marker Therapeutics, Inc. | 23.68M |
| Denali Therapeutics, Inc. | 2.955B |
Market Cap Related Metrics
| PE Ratio | 24.36 |
| PS Ratio | 5.242 |
| PEG Ratio | 0.202 |
| Price to Book Value | 4.675 |
| Price to Free Cash Flow | 19.56 |
| Price | 158.42 |
| Earnings Yield | 4.11% |
| PEGY Ratio | 0.202 |
| Operating PE Ratio | 20.36 |
| Normalized PE Ratio | 24.70 |